PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33704910-0 2021 Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-alpha, BAX, and VEGF immunoexpression via an antioxidant mechanism. Trimetazidine 0-13 tumor necrosis factor Rattus norvegicus 75-84 27348619-7 2016 TMZ treatment also significantly attenuated CSP-induced oxidative stress and suppressed elevated levels of TNF-alpha and IL-6 and NF-kappaB expression and its DNA-binding activity caused by CSP administration. Trimetazidine 0-3 tumor necrosis factor Rattus norvegicus 107-116 25665480-8 2015 Trimetazidine also significantly decreased the levels of IL-1ss and TNF-a which are the proinflammatory cytokines (p < 0.05). Trimetazidine 0-13 tumor necrosis factor Rattus norvegicus 68-73